Postencephalitic Parkinsonism: Unique Pathological and Clinical Features-Preliminary Data

Sabrina Strobel1, Jeswinder Sian-Hulsmann2, Dennis Tappe3

  • 1Institute of Pathology, Department of Neuropathology, University of Wuerzburg, 97080 Wuerzburg, Germany.

Cells
|September 27, 2024
PubMed

Insights

Postencephalitic parkinsonism (PEP) lacks iron pathology, unlike Parkinson's disease (PD). PEP shows tau pathology and memory deficits, suggesting different treatment strategies are needed for these parkinsonian syndromes.

Area of Science:

  • Neurology
  • Neuroscience
  • Pathology

Background:

  • Postencephalitic parkinsonism (PEP) presents with motor disturbances similar to Parkinson's disease (PD).
  • PEP is hypothesized to have a virus-induced etiology, distinct from PD's α-synuclein/Lewy body pathology.
  • Previous observations suggest PEP lacks the iron-induced pathology characteristic of PD.

Purpose of the Study:

  • To investigate and compare iron-induced pathology in post-mortem brain tissue between PEP and PD.
  • To elucidate the distinct pathological features of PEP compared to idiopathic PD.

Main Methods:

  • Histochemical analysis of paraffin-embedded post-mortem brain tissue.
  • Comparative study focusing on iron deposition in brain samples from PEP and PD groups.

Main Results:

  • Iron deposits were notably absent in the PEP group, with only minimal perivascular depositions in one case.
  • PEP brain tissue exhibited tau-protein pathology and neurofibrillary tangles.
  • Mild to moderate memory deficits were observed in PEP cases.

Conclusions:

  • The absence of iron pathology in PEP suggests it is fundamentally different from PD and cannot be treated with iron chelators.
  • PEP's pathology is linked to tau-protein and neuroinflammation, potentially triggered by viral infections and immunological dysfunction.
  • Standard PD treatments like L-Dopa may offer limited efficacy for PEP symptoms.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
495
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
235
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
513
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Postsynaptic Potential (PSP)01:32

Postsynaptic Potential (PSP)

Postsynaptic potential (PSP) refers to a change in the electrical potential of a neuron when neurotransmitters released by presynaptic neurons bind to postsynaptic receptors. This potential can either be excitatory, leading to depolarization and ultimately action potential generation, or inhibitory, leading to hyperpolarization and suppression of the postsynaptic neuron.
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
2.4K